374Water Strengthens Management Team with Addition of Peter Mandel as General Counsel
374Water Inc. (NASDAQ:SCWO) has appointed Peter Mandel as General Counsel, effective August 19, 2024. Mandel brings extensive experience in corporate and securities law, public company representation, and capital markets transactions. He will oversee the company's legal functions and advise the management team and Board of Directors as 374Water scales its operations and commercializes its AirSCWO technology.
Mandel's previous roles include General Counsel at HALO Precision Diagnostics and Head of Corporate Legal at Olema Oncology. He also worked at Latham & Watkins LLP and Cooley LLP, representing technology and biotechnology companies. Mandel holds a J.D. from Stanford Law School and a B.A. from UC Berkeley.
374Water Inc. (NASDAQ:SCWO) ha nominato Peter Mandel come Consigliere Generale, con effetto dal 19 agosto 2024. Mandel porta con sé una vasta esperienza nel diritto societario e dei titoli, nella rappresentanza di società pubbliche e nelle transazioni nei mercati dei capitali. Supervisionerà le funzioni legali dell'azienda e fornirà consulenza al team di gestione e al Consiglio di Amministrazione mentre 374Water espande le proprie operazioni e commercializza la propria tecnologia AirSCWO.
I ruoli precedenti di Mandel includono Consigliere Generale presso HALO Precision Diagnostics e Responsabile Legale Aziendale di Olema Oncology. Ha inoltre lavorato presso Latham & Watkins LLP e Cooley LLP, rappresentando aziende nel settore tecnologico e biotecnologico. Mandel ha conseguito un J.D. presso la Stanford Law School e una laurea in B.A. presso UC Berkeley.
374Water Inc. (NASDAQ:SCWO) ha nombrado a Peter Mandel como Consejero General, con efecto a partir del 19 de agosto de 2024. Mandel aporta una amplia experiencia en derecho corporativo y de valores, representación de empresas públicas y transacciones en los mercados de capitales. Supervisará las funciones legales de la compañía y asesorará al equipo de gestión y a la Junta Directiva mientras 374Water expande sus operaciones y comercializa su tecnología AirSCWO.
Los roles previos de Mandel incluyen Consejero General en HALO Precision Diagnostics y Jefe de Asuntos Legales Corporativos en Olema Oncology. También trabajó en Latham & Watkins LLP y Cooley LLP, representando a empresas de tecnología y biotecnología. Mandel tiene un J.D. de la Stanford Law School y una licenciatura de la UC Berkeley.
374Water Inc. (NASDAQ:SCWO)가 Peter Mandel을 법률 고문으로 임명하였으며, 2024년 8월 19일부터 효력이 발생합니다. Mandel은 기업 및 증권법, 공기업 대표 및 자본 시장 거래에 대한 방대한 경험을 제공합니다. 그는 회사의 법률 기능을 감독하고, 374Water가 운영을 확장하고 AirSCWO 기술을 상용화하는 동안 경영진 및 이사회에 조언할 것입니다.
Mandel의 이전 역할에는 HALO Precision Diagnostics의 법률 고문 및 Olema Oncology의 기업 법률 책임자가 포함됩니다. 그는 또한 기술 및 생명 과학 회사를 대표하며 Latham & Watkins LLP와 Cooley LLP에서 근무했습니다. Mandel은 Stanford Law School에서 J.D.를, UC Berkeley에서 B.A.를 취득했습니다.
374Water Inc. (NASDAQ:SCWO) a nommé Peter Mandel au poste de Conseiller Général, à compter du 19 août 2024. Mandel possède une vaste expérience en droit des sociétés et en droit des valeurs mobilières, ainsi qu'en représentation de sociétés publiques et en transactions sur les marchés financiers. Il supervisera les fonctions juridiques de l'entreprise et conseillera l'équipe de direction et le Conseil d'Administration alors que 374Water étend ses opérations et commercialise sa technologie AirSCWO.
Les précédents postes de Mandel comprennent Conseiller Général chez HALO Precision Diagnostics et Responsable du Droit des Sociétés chez Olema Oncology. Il a également travaillé chez Latham & Watkins LLP et Cooley LLP, représentant des entreprises de technologie et de biotechnologie. Mandel détient un J.D. de la Stanford Law School et un B.A. de l'UC Berkeley.
374Water Inc. (NASDAQ:SCWO) hat Peter Mandel zum General Counsel ernannt, mit Wirkung zum 19. August 2024. Mandel bringt umfangreiche Erfahrungen im Unternehmens- und Wertpapierrecht, in der Vertretung öffentlicher Unternehmen sowie in Transaktionen auf den Kapitalmärkten mit. Er wird die Rechtsabteilungen des Unternehmens überwachen und das Managementteam sowie den Vorstand beraten, während 374Water seine Geschäftstätigkeiten ausweitet und die AirSCWO-Technologie kommerzialisiert.
Mandels frühere Positionen umfassen General Counsel bei HALO Precision Diagnostics und Leiter der Unternehmensrechtsabteilung bei Olema Oncology. Er arbeitete auch bei Latham & Watkins LLP und Cooley LLP, wo er Technologie- und Biotechnologieunternehmen vertrat. Mandel hat einen J.D. von der Stanford Law School und einen B.A. von der UC Berkeley.
- Appointment of experienced General Counsel to strengthen the management team
- Addition of legal expertise to support company growth and technology commercialization
- None.
DURHAM, NC / ACCESSWIRE / August 15, 2024 / 374Water Inc. (NASDAQ:SCWO), a global leader in organic waste destruction technology for the municipal, federal and industrial markets, today announced the appointment of Peter Mandel as General Counsel, effective August 19, 2024. With extensive experience in corporate and securities law, public company representation, and transformative capital markets transactions, Mr. Mandel will oversee the Company's legal functions while serving as a trusted adviser to the management team and Board of Directors as it scales its operations and commercializes its innovative technology.
"As we grow our organization, we are excited to welcome Peter to 374Water's executive team," said Chris Gannon, CEO of 374Water. "His legal expertise, business acumen, and strategic insight will be instrumental as we scale our business and commercialize our AirSCWO technology. With his extensive experience, Peter will be a key partner in shaping our strategies for long-term sustainable growth and ensuring the tactical execution of key initiatives. He will play a critical role in driving our mission to deliver innovative waste destruction technologies and capitalize on expanding market opportunities."
Previously, Mandel served as General Counsel at HALO Precision Diagnostics, where he led the legal function and provided guidance on risk mitigation and business operations, executed business transactions and advised the board on corporate governance matters. Prior to his role at HALO Precision Diagnostics, he was Head of Corporate Legal at Olema Oncology, a publicly traded biotech where he was instrumental in the company's initial public offering and subsequent public filings, governance and securities compliance, overseeing equity compensation programs and managing board matters. Mandel began his legal career at Latham & Watkins LLP and later joined Cooley LLP, representing numerous high-profile public and private technology and biotechnology companies across a multitude of strategic and capital markets transactions. Mandel holds a J.D. from Stanford Law School and a B.A. with honors from the University of California, Berkeley. Mr. Mandel holds a J.D. from Stanford Law School and a B.A. with honors from the University of California, Berkeley.
"I'm honored to join 374Water and contribute to a company with such a compelling mission and innovative technology," said Peter Mandel. "This is a unique opportunity to help shape the future of this company and capitalize on the tremendous opportunities ahead to deliver sustainable waste destruction solutions. I look forward to working closely with Chris, the Board, and the entire team to drive strategies that advance our mission, support growth and innovation initiatives, and deliver long-term value to our stakeholders."
About 374Water
374Water Inc. (NASDAQ:SCWO) is a global cleantech company providing innovative solutions addressing wastewater treatment and waste management issues within the municipal, federal and industrial markets. 374Water's AirSCWO technology efficiently destroys a range of non-hazardous and hazardous organic wastes producing safe dischargeable water streams, safe mineral effluent, safe vent gas, and recoverable heat energy. 374Water is leading a new era of creating value in sustainability, eliminating PFAS and protecting our communities. Learn more by visiting www.374water.com and follow us on LinkedIn.
Cautionary Language on Forward-Looking Statements
Certain statements in this communication are "forward-looking statements" within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995, as amended. These statements relate to future events or our future financial performance, including statements relating to our ability to execute on our strategic plan and the results of our 2024 Annual Meeting and involve known and unknown risks, uncertainties, and other factors that may cause our actual results, levels of activity, performance, or our achievements or those of our industry to be materially different from those expressed or implied by any forward-looking statements. In some cases, forward-looking statements may be identified by the use of words like "may," "will," "could," "would," "should," "expect," "plan," "anticipate," "intend," "believe," "estimate," "project," "consider," "predict," "potential," "feel," or other comparable terminology. The Company has based these forward-looking statements on its current expectations, assumptions, estimates, beliefs, and projections. While the Company believes these expectations, assumptions, estimates, and projections are reasonable, such forward-looking statements are only predictions and involve known and unknown risks and uncertainties, many of which involve factors or circumstances that are beyond the Company's control. These and other important factors, including those discussed under "Risk Factors" in our Annual Report on Form 10-K for the year ended December 31, 2023, as well as the Company's subsequent filings with the SEC, may cause actual results, performance, or achievements to differ materially from those expressed or implied by these forward-looking statements. The forward-looking statements herein are made only as of the date they were first issued, and unless otherwise required by applicable securities laws, the Company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise.
Investor Contact:
Heather Crowell
ir@374water.com
Media Contact:
Christian Rizzo
media@374water.com
SOURCE: 374Water Inc.
View the original press release on accesswire.com
FAQ
When will Peter Mandel start as General Counsel at 374Water (SCWO)?
What is Peter Mandel's educational background?
What is 374Water's (SCWO) main technology?
What was Peter Mandel's role before joining 374Water (SCWO)?
